The cost of CF care can vary widely depending on a number of factors, including the health status of the CF population, practice patterns, availability of treatments (e.g., cystic fibrosis conductance transmembrane [CFTR] modulators) and the type of healthcare system (public vs. private) of each country. This evidence concerns the gene CFTR and cystic fibrosis.